Literature DB >> 2125713

Muscarinic receptors mediate the release of arachidonic acid from spinal cord and hippocampal neurons in primary culture.

R Y Kanterman1, A L Ma, E M Briley, J Axelrod, C C Felder.   

Abstract

Muscarinic receptors are involved in CNS neurotransmissions and have been shown to transduce their message by modulating cAMP, calcium, inositol phosphates, and more recently, by liberating arachidonic acid via phospholipase A1. We have previously shown that the alpha 1-adrenergic and 5-HT2 serotonergic neurotransmitter receptors cause the release of arachidonic acid from spinal cord and hippocampal neurons, respectively, in primary culture. In this study, we demonstrated a muscarinic receptor-mediated release of arachidonic acid in these two neural segments which occurred independent of phosphatidylinositol-specific phospholipase C. This release of arachidonic acid was neuronal (not glial) in origin and exhibited M1 muscarinic receptor pharmacology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125713     DOI: 10.1016/0304-3940(90)90635-m

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Arachidonic acid inhibits transient potassium currents and broadens action potentials during electrographic seizures in hippocampal pyramidal and inhibitory interneurons.

Authors:  S Keros; C J McBain
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  Tumor-suppressor function of muscarinic acetylcholine receptors is associated with activation of receptor-operated calcium influx.

Authors:  C C Felder; L MacArthur; A L Ma; F Gusovsky; E C Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

3.  Hyperpolarizing muscarinic responses of freshly dissociated rat hippocampal CA1 neurones.

Authors:  M Wakamori; H Hidaka; N Akaike
Journal:  J Physiol       Date:  1993-04       Impact factor: 5.182

4.  Arachidonic acid mediates muscarinic inhibition and enhancement of N-type Ca2+ current in sympathetic neurons.

Authors:  Liwang Liu; Ann R Rittenhouse
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-20       Impact factor: 11.205

Review 5.  Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.